COMMUNIQUÉS West-GlobeNewswire

ERYTECH Announces Filing of 2018 “Document de Référence” and 2018 Annual Report on Form 20-F
29/03/2019
LYON, France, March 29, 2019 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris: ERYP – Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative by encapsulating therapeutic drug substances inside [...]
ERYTECH annonce le dépôt de son Document de Référence 2018 et de son Form 20-F 2018
29/03/2019
LYON, France, 29 mars 2019 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris : ERYP – Nasdaq : ERYP), société biopharmaceutique de stade clinique qui développe des thérapies innovantes en encapsulant des médicaments [...]
Constitution of the Board of Directors in Genmab A/S and Grant of Restricted Stock Units and Warrants to Employees in Genmab
29/03/2019
Company Announcement Copenhagen, Denmark; March 29, 2019 – Following Genmab A/S’ (Nasdaq Copenhagen: GEN) Annual General Meeting held on March 29, 2019, the Company’s Board of Directors met to constitute itself. Mr. [...]
Award of Share Options
29/03/2019
Summit Therapeutics plc (‘Summit’ or the ‘Company’) Award of Share Options Oxford, UK, and Cambridge, MA, US, 29 March 2019 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), a leader in new mechanism antibiotic [...]
Award of Share Options
29/03/2019
Summit Therapeutics plc (‘Summit’ or the ‘Company’) Award of Share Options Oxford, UK, and Cambridge, MA, US, 29 March 2019 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), a leader in new mechanism antibiotic [...]
ReWalk Robotics Completes One-for-Twenty-Five Reverse Share Split
29/03/2019
YOKNEAM ILIT, Israel and MARLBOROUGH, Mass., March 29, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ ReWalk ” or the “ Company ”) reported today that it has completed the reverse share split of ReWalk [...]
Kiadis Pharma Announces Results of Extraordinary General Meeting of Shareholders
29/03/2019
Kiadis Pharma Announces Results of Extraordinary General Meeting of Shareholders Amsterdam, The Netherlands, March 29, 2019 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS [...]
Genfit: GENFIT Announces Closing of Global Offering and Full Exercise of Underwriters’ Option to Purchase Additional American Depositary Shares
29/03/2019
FOR IMMEDIATE RELEASE GENFIT Announces Closing of Global Offering and Full Exercise of Underwriters’ Option to Purchase Additional American Depositary Shares Global Offering Gross Proceeds Totaling $155.4 Million Lille [...]
Genfit : GENFIT annonce le règlement-livraison de l’Offre Globale
29/03/2019
CE COMMUNIQUÉ N’EST PAS DESTINÉ A ÊTRE PUBLIÉ, DISTRIBUÉ OU DIFFUSÉ, DIRECTEMENT OU INDIRECTEMENT, AUX ÉTATS-UNIS D’AMÉRIQUE NI À DES RESSORTISSANTS AMÉRICAINS (« U.S. PERSONS »), POUR LEUR BÉNÉFICE OU POUR LEUR COMPTE [...]
Vigil Health Solutions Establishes Automatic Share Purchase Plan
29/03/2019
VICTORIA, British Columbia, March 29, 2019 (GLOBE NEWSWIRE) -- Vigil Health Solutions Inc. (“ V i g i l ” or the “ Company ”) (TSX-VEN: VGL) today announced that, in connection with its previously announced normal [...]
Increase in the number of shares and votes in Oasmia Pharmaceutical AB (publ)
29/03/2019
The number of shares and votes in Oasmia Pharmaceutical AB (publ) has increased as a result of the directed new share issue carried out in March 2019. Through the directed share issue the number of outstanding shares [...]
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 28 février 2019
29/03/2019
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 28 février 2019 En application de l'article L. 233-8 II du code de commerce et de l'article 222-12-5 du règlement général de l'AMF, [...]
Ossur Hf : Registration of capital reduction of 5,430,259 shares completed
29/03/2019
Announcement no. 21/2019 29 March 2019 Registration of capital reduction of 5,430,259 shares completed Reference is made to the Company's announcement no. 16/2019 published on 7 March 2019. The capital reduction of ISK [...]
ImmuCell Corporation Announces Closing of $9 Million Public Offering of Common Stock
29/03/2019
PORTLAND, Maine, March 29, 2019 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and [...]
Cytovance Biologics Congratulates Siwa Biotech on Commercial Medical Device Approval
29/03/2019
OKLAHOMA CITY, March 29, 2019 (GLOBE NEWSWIRE) -- Cytovance Biologics announces Siwa Biotech’s receipt of FDA licensure of Anti-Fy a and Anti-Fy b recombinant monoclonal Blood Grouping Reagents. These reagents were [...]
Summary of capital reduction pursuant to Article 32 of the Danish Capital
29/03/2019
Please read the full announcement here Attachment 2019_05_Summary_of_capital_reduction_EN
Theratechnologies Appoints New Board Member
29/03/2019
MONTREAL, March 29, 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced the appointment of Ms. Sheila M. Frame as a new independent member to its Board of Directors. “Sheila is [...]
Theratechnologies nomme un nouveau membre à son conseil d’administration
29/03/2019
MONTRÉAL, 29 mars 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Société) (TSX: TH) a annoncé aujourd’hui la nomination de Mme Sheila M. Frame à titre d’administratrice indépendante du conseil d’administration de la [...]
Reduction of common stock
29/03/2019
Please read the full announcement here Attachment 2019_04_Reduction_of_common_stock_EN

Pages